Gene expression profiling in ethnic Malays with type 2 diabetes mellitus, with and without diabetic nephropathy

Journal of Nephrology

Volumn 24, Issue 6, 2011, Pages 778-789

  Lokman, Faradianna E ^a   Seman, Norhashimah A ^a   Ismail, Azizal Safi ^b   Yaacob, Nor Azwany ^b   Mustafa, Norlaila ^c   Khir, Amir S M ^d   Hussein, Zanariah ^e   Mohamud, Wan Nazaimoon Wan ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^d PENANG MEDICAL COLLEGE   (Malaysia)

^e PUTRAJAYA HOSPITAL   (Malaysia)

Author keywords

Diabetic nephropathy; Gene expression; Malay; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; COMPLEMENT COMPONENT C3A; CREATININE; HLA C ANTIGEN; MONOCARBOXYLATE TRANSPORTER 4; PHOSPHOPROTEIN PHOSPHATASE 1; SODIUM PROTON EXCHANGE PROTEIN;

ADULT; ARTICLE; BMP2K GENE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DOWN REGULATION; ETHNIC GROUP; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; HLA C GENE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PROTEIN URINE LEVEL; SLC12A1 GENE; SLC16A3 GENE; SLC7A2 GENE; SLC9A8 GENE; UPREGULATION;

AGED; ALBUMINURIA; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY FAILURE, CHRONIC; MALAYSIA; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; RENAL DIALYSIS; UP-REGULATION;

EID: 80955163961     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.6382     Document Type: Article

References (35)

1. Garella S. The costs of dialysis in the USA. Nephrol Dial Transplant. 1997;12(Suppl 1):10-21.
2. Hooi LS, Wong HS, Morad Z. Prevention of renal failure: The Malaysian experience. Kidney Int Suppl. 2005;94:S70-S74.
3. Institute for Public Health. The Third National Health and Morbidity Survey 2006. Vol. 2. Malaysia: Ministry of Health; 2008.
4. Freedman BI, Bostrom M, Daeihagh P, et al. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol. 2007;2:1306-1316.
5. Krolewski AS, Waram JHR, Rand LI, et al. Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med. 1987;317:1390-1398.
6. Quinn M, Angelico MC, Warram JH, et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39(8):940-945.
7. Hoheisel JD. Microarray technology: beyond transcript profil-ing and genotype analysis. Nat Rev Genet. 2006;7:200-210.
8. Baelde HJ, Eikmans M, Doran PP, et al. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis. 2004;43:636-650.
9. Conway BR, Martin R, McKnight AJ, Savage DA, Brady HR, Maxwell AP. Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy. Nephrol Dial Transplant. 2004;19:2019-2024. Published online June 8, 2004.
10. Mollsten A, Marklund SL, Wessman M, et al. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes. 2007;56:265-269.
11. Lee SJ, Choi MG, Kim DS, et al. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism. 2006;55:1-7.
12. Nomiyama T, Tanaka Y, Piao L, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 2003;48:138-141.
13. Bao L, Osawe I, Haas M, et al. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J Immunol. 2005;175:1947-1955.
14. Makino H, Miyamoto Y, Sawai K, et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes. 2006;55:2747-2756.
15. Molitch ME, DeFronzo RA, Franz MJ, et al. American Diabetes Association. Nephropathy in diabetes [position statement]. Diabetes Care. 2004;27(Suppl 1):s79-s83.
16. Barbosa J, Saner B. Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia. 1984;27:487-492.
17. Pérez-Luque E, Malacara JM, Olivo-Díaz A, et al. Contribution of HLA class II genes to end stage renal disease in Mexican patients with type 2 diabetes mellitus. Hum Immunol. 2000;61:1031-1038.
18. Dyck R, Bohm C, Klomp H. Increased frequency of HLA A2/ DR4 and A2/DR8 haplotypes in young Saskatchewan Aboriginal people with diabetic end-stage renal disease. Am J Nephrol. 2003;23:178-185.
19. Williams RC, Knowler WC, Butler WJ, et al. HLA-A2 and type 2 (insulin independent) diabetes mellitus in Pima Indians: an association of allele frequency with age. Diabetologia. 1981;21:460-463.
20. Serjeantson SW, Owerbach D, Zimmet P. Genetics of diabetes in Nauru: effects of foreign admixture, HLA antigens and the insulin gene linked polymorphism. Diabetologia. 1983;25:13-17.
21. Dittimer I, Woodfield G, Simpson I. Non-insulin dependent diabetes mellitus in New Zealand Maori: a relationship with class I but not class II histocompatibility locus antigens. N Z Med J. 1998;111:294.
22. He L, Vasiliou K, Nebert DW. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics. 2009;3:195-206.
23. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Introduction. Pflugers Arch. 2004;447:465-468. Published online November 18, 2003.
24. Kim JH, Shin HD, Park BL, et al. SLC12A3 (solute carrier family 12 member (sodium/chloride 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy. Diabetes. 2006;55:843-848.
25. Nishiyama K, Tanaka Y, Nakajima K, et al. Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study. Diabetologia. 2005;48:1335-1338.
26. Guttula SV, Rao AA, Sridhar GR, et al. Cluster analysis and phylogenetic relationship in biomarker identification of type 2 diabetes and nephropathy. Int J Diabetes Dev Ctries. 2010;30:52-56.
27. Tang Z, Lu B, Hatch E, et al. C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol. 2009;20:593-603.
28. Mollsten A, Wessman M, Svensson M, et al. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Ann Med. 2006;38:522-528.
29. Petersen KF, Shulman GI. Cellular mechanism of insulin resistance in skeletal muscle. J R Soc Med. 2002;95(Suppl 42):8-13.
30. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003;100:8466-8471.
31. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1 alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267-273.
32. Zelezniak A, Pers TH, Soares S, Patti ME, Patil KR. Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLOS Comput Biol. 2010;6:E1000729.
33. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β and -γ in adult rat. Endocrinology. 1996;137:354-366.
34. Mukherjee R, Jow L, Croston GE, Paterniti JR Jr. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPAR-γ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem. 1997;272:8071-8076.
35. Kume S, Uzu T, Isshiki K, Koya D. Peroxisome proliferatoractivated receptors in diabetic nephropathy. PPAR Res. 2008;2008:879523. doi:10.1155/2008/879523.